This study proposes an innovative and scalable solution to increase oral bioavailability
In this study, the performance of Capsugel® Enprotect® capsules was evaluated using the DGM-intestinal model after intake in fasted and fed state and compared to in vivo data.
This study shows that Capsugel® Enprotect® capsules are stable and compatible with standard FMT placebo formulation
Poster presentation delivered at the Controlled Release Society (CRS) Annual Meeting, 2025.
Capsule-based Dry Powder Inhaler (cDPI) represents a prominent solution in the inhalation therapy domain. This poster explores the influence of capsule type on cDPI performance.